An Open-Label Study of Azetukalner in Major Depressive Disorder
Clinical trial NCT06922110 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06922110
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-18
- Primary completion
- 2027-01-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.